Protective effect of pyridoxamine on RPE cells treated with AGEs
Author:
Fund Project:

Natural Science Foundation of Fujian Province in 2016(No.2016J01155)

  • Article
  • | |
  • Metrics
  • |
  • Reference [11]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    AIM: To observe the effects of pyridoxamine(PM)on RAGE, ROS and apoptosis in RPE cells treated with advanced glycation end products(AGEs), and to investigate the protective effect of PM on RPE cells in diabetic retinopathy.

    METHODS:Primary cultured human RPE cells, the third generation of cells were synchronized with serum-free Dulbecco-modified Eagle medium for 24h, and then grouped: 1)Control group: cultured with 100mg/L BSA for 48h; 2)AGEs-treated group: cultured with 200mg/L AGEs for 48h; 3)PM group: PM1 group: cultured with 16mg/L PM+200mg/L AGEs for 48h; PM2 group: cultured with 32mg/L PM+200mg/L AGEs for 48h. The expression of RAGE protein was detected by immunohistochemistry. The formation of ROS was observed by fluorescence microscopy. The apoptosis of cells was detected by TUNEL.

    RESULTS:The expression of RAGE protein, ROS and apoptosis of RPE cells in PM group were significantly lower than those in AGEs-treated group, and decreased with the increase of PM concentration.

    CONCLUSION:Pyridoxamine can inhibit the expression of RAGE and the production of ROS, reduce apoptosis, and have a protective effect on RPE cells.

    Reference
    1 Stitt AW. AGEs and diabetic retinopathy. Invest Ophthalmol Vis Sci 2010; 51(10):4867-4874
    2 Yamagishi S,Nakamura K,Matsui T. Advanced glycation end products(AGEs)and their receptor(RAGE)system in diabetic retinopathy. Curr Drug Discov Technol 2006; 3(1):83-88
    3 黄焱,周敏,郑卫东,等.高级糖基化终末产物对人视网膜色素上皮细胞的作用机制研究.中华眼底病杂志 2013; 29(5):510-513
    4 Huang Y,Xu G,Peng Y,et al. Photodynamic effects of ZnPcS(4)-BSA in human retinal pigment epithelium cells. J Ocul Pharmacol Ther 2009; 25(3):231-238
    5 Zheng Y,He M,Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol 2012; 60(5):428-431
    6 Thomas MC,Forbes JM,Cooper ME. Advanced glycation end products and diabetic nephropathy. Am J Ther 2005; 12(6):562-572
    7 Zong H,Ward M,Stitt AW. AGEs,RAGE,and diabetic retinopathy. Curr Diab Rep 2011; 11(4):244-252
    8 郑炜平,朱鹏立,李峰,等.吡哆胺和替米沙坦对自发性高血压大鼠心肌重塑相关指标的影响.中国循环杂志2015; 30(7):689-693
    9 黄焱,郑卫东,修惠平,等.吡哆胺对糖尿病大鼠视皮质AGE-RAGE系统的影响.中国组织化学与细胞化学杂志2014; 23(1):55-59
    10 Stitt A,Gardiner TA,Alderson NL,et al. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 2002; 51(9):2826-2832
    11 Thotala D,Cheytrkin S,Hudson D,et al. Pyridoxamine protects intestinal epithelium from ionizing radiation-induced apoptosis. Free Radic Biol Med 2009; 47(6):779-785
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Min Zhou, Yan Huang, Qiao-Ling Lai,/et al.Protective effect of pyridoxamine on RPE cells treated with AGEs. Guoji Yanke Zazhi( Int Eye Sci) 2018;18(10):1778-1781

Copy
Share
Article Metrics
  • Abstract:955
  • PDF: 1038
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:June 08,2018
  • Revised:August 28,2018
  • Online: September 14,2018